Literature DB >> 15339958

Fenretinide activates a distinct apoptotic pathway.

Ethan Dmitrovsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339958     DOI: 10.1093/jnci/djh268

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.

Authors:  Frank Peinemann; Elvira C van Dalen; Heike Enk; Frank Berthold
Journal:  Cochrane Database Syst Rev       Date:  2017-08-25

2.  Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation.

Authors:  Haw-Jyh Chiu; Donald A Fischman; Ulrich Hammerling
Journal:  FASEB J       Date:  2008-08-01       Impact factor: 5.191

3.  Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis.

Authors:  Hilal Kocdor; Mehmet Ali Kocdor; Tulay Canda; Duygu Gurel; Ruksan Cehreli; Osman Yilmaz; Mehmet Alakavuklar; Gul Guner
Journal:  Clin Transl Oncol       Date:  2009-04       Impact factor: 3.405

4.  Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer.

Authors:  Bryan J Schneider; Francis P Worden; Shirish M Gadgeel; Ralph E Parchment; Collette M Hodges; James Zwiebel; Rodney L Dunn; Antoinette J Wozniak; Michael J Kraut; Gregory P Kalemkerian
Journal:  Invest New Drugs       Date:  2009-02-19       Impact factor: 3.850

5.  AF1q: a novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells.

Authors:  Paola Tiberio; Elena Cavadini; Maurizio Callari; Maria Grazia Daidone; Valentina Appierto
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.